Method of inhibiting phosphodiesterases with substituted alkanohydroxamic acids
申请人:——
公开号:US20010049371A1
公开(公告)日:2001-12-06
Imido and amido substituted alkanohydroxamic acids reduce the levels of TNF&agr; and inhibit phosphodiesterase in a mammal. A typical embodiment is 3-(3-cyclopentyloxy-4-methoxyphenyl)-N-hydroxy-3-phthalimidopropionamide.
Substituted alkanohydroxamic acids and method of reducing TNFalpha levels
申请人:——
公开号:US20040006096A1
公开(公告)日:2004-01-08
Imido and Amido substituted alkanohydroxamic acids reduce the levels of TNFa and inhibit phosphodiesterase in a mammal. A typical embodiment is 3-(3-cyclopentyloxy-4-methoxyphenyl)-N-hydroxy-3-phthalimidopropionamide.
Substituted acylhydroxamic acids and method of reducing TNFalpha levels
申请人:Celgene
公开号:US20040167174A1
公开(公告)日:2004-08-26
Imido and amido substituted acyihydroxamidic acids which reduce the levels of TNF&agr; and inhibit phosphodiesterase in a mammal. A typical embodiment is (3-(1,3-dioxoisoindolin -2-yl)-3-(3-ethoxy-4-methoxyphenyl)propandylamino)propanoate.